Deakin University
Browse

Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial

Version 2 2024-06-02, 23:39
Version 1 2023-08-16, 03:52
journal contribution
posted on 2024-06-02, 23:39 authored by S Peters, J-L Pujol, U Dafni, M Dómine, S Popat, M Reck, J Andrade, A Becker, D Moro-Sibilot, A Curioni-Fontecedro, O Molinier, K Nackaerts, A Insa Mollá, R Gervais, G López Vivanco, J Madelaine, J Mazieres, M Faehling, F Griesinger, M Majem, JL González Larriba, M Provencio Pulla, K Vervita, H Roschitzki-Voser, B Ruepp, P Mitchell, RA Stahel, C Le Pechoux, D De Ruysscher, Ann LivingstoneAnn Livingstone
Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial

History

Journal

Annals of Oncology

Volume

33

Pagination

67-79

Location

Amsterdam, The Netherlands

ISSN

0923-7534

Language

en

Publication classification

C1.1 Refereed article in a scholarly journal

Issue

1

Publisher

Elsevier

Usage metrics

    Research Publications

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC